v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2026
Sep. 30, 2025
Current Assets:    
Cash and cash equivalents $ 16,563,705 $ 3,924,908
Accounts receivable, net of allowances 686,235
Inventory 22,625,945 22,286,693
Prepaid expenses 2,831,280 1,331,280
Total Current Assets 42,707,165 27,542,881
Other Assets:    
In-process research and development, net of accumulated amortization 69,385,938 73,400,000
Total Assets 112,093,103 100,942,881
Current Liabilities:    
Accounts payable 7,315,516 13,234,684
License payable 15,650,000 22,650,000
Accrued expenses 25,836,120 4,093,124
Total Current Liabilities 58,787,194 49,491,579
Notes payable, net of deferred financing costs 6,410,161
Deferred tax liability 2,710,643 2,784,960
Total Liabilities 71,708,109 56,076,650
Stockholders’ Equity:    
Preferred stock - $0.0001 par value; 10,000,000 shares authorized: no shares issued and outstanding
Common stock - $0.0001 par value; 400,000,000 shares authorized at June 30, 2026 and September 30, 2025; 105,758,982 and 83,513,442 shares issued and outstanding at June 30, 2026 and September 30, 2025, respectively 10,576 8,351
Additional paid-in capital 145,481,984 108,897,836
Accumulated deficit (105,107,566) (64,039,956)
Total Stockholders’ Equity 40,384,994 44,866,231
Total Liabilities and Stockholders’ Equity 112,093,103 100,942,881
Related Party    
Current Liabilities:    
Due to related party 9,985,558 9,513,771
Note payable to related party $ 3,800,111 $ 3,800,111